跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack
Approved
STANDARD
TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2f68fb8a47565702
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2f68fb8a47565702
Product Name
TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack
Artg Id
393303
Artg Name
TIOCIP tiotropium (as bromide monohydrate) 18 microgram powder for inhalation (in capsule) blister pack
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2023-09-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2f68fb8a47565702
Type
Standard
Back to TGA Approvals